[Recombinant erythropoietins--an alternative therapy to red cell blood transfusions in infants with hereditary spherocytosis].
Hereditary spherocytosis is the most frequently occurring haemolytic anaemia. Some patients manifest clinical signs during the neonatal period and require transfusion. A case of hereditary spherocytosis in neonate is presented. The use of rhEPO during the first months may be an alternative therapy to red cell transfusion.
Neuman-Łaniec
Magdalena
M
Klinika Pediatrii Hematologii Onkologii i Endokrynologii AM w Gdańsku.
Wierzba
Jolanta
J
Irga
Ninela
N
Wasilewska
Eliza
E
Balcerska
Anna
A
D017707:Erythrocyte Transfusion; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006454:Hemoglobins / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D011994:Recombinant Proteins; D013103:Spherocytosis, Hereditary / Q000097:blood / Q000188:drug therapy* / Q000235:genetics; D013997:Time Factors; D016896:Treatment Outcome
D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin